R. W. Gruessner and A. C. Gruessner, The current state of pancreas transplantation, Nat Rev Endocrinol, vol.9, pp.555-62, 2013.

F. Burron, O. Thaunat, S. Demuylder-mischler, L. Badet, M. Brunet et al., Pancreas retransplantation: a second chance for diabetic patients?, Transplantation, vol.95, pp.347-52, 2013.

U. Kielgast, T. Krarup, J. J. Holst, and S. Madsbad, Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function, Diabetes Care, vol.34, pp.1463-1471, 2011.

T. Froud, R. N. Faradji, A. Pileggi, S. Messinger, D. A. Baidal et al., The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects, Transplantation, vol.86, pp.36-45, 2008.

R. N. Faradji, T. Froud, S. Messinger, T. Froud, A. Pileggi et al., Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction, Cell Transplant, vol.18, pp.1247-59, 2009.

M. R. Rickels and A. Naji, Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients, Diabetes Obes Metab, vol.12, pp.731-734, 2010.

N. R. Pinelli, A. Patel, and F. D. Salinitri, Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series, Diabetes Care, vol.36, pp.171-173, 2013.